What are the best treatments for Anti-NMDA Receptor Encephalitis?

Anti-NMDA receptor encephalitis is primarily treated through a combination of tumor removal (if an underlying teratoma is present) and aggressive immunotherapy to suppress the overactive immune response. While treatment protocols are highly personalized, most patients receive a structured regimen of first-line therapies, often followed by second-line medications if improvement is not observed within 10–14 days.

What are the first-line treatments for Anti-NMDA receptor encephalitis?

The standard of care for Anti-NMDA receptor encephalitis focuses on removing the source of autoantibodies and clearing the antibodies from the blood. First-line immunotherapies typically include:

• Intravenous Methylprednisolone (Solu-Medrol): High-dose corticosteroids to reduce systemic inflammation.


• Intravenous Immunoglobulin (IVIG): Pooled antibodies to neutralize the patient's own pathogenic antibodies.


• Plasmapheresis (Plasma Exchange): A procedure to mechanically filter autoantibodies directly out of the plasma.

Which second-line medications are used for persistent symptoms?

If a patient with Anti-NMDA receptor encephalitis does not respond to first-line therapies, neurologists may escalate to second-line treatments to further deplete B-cells or modulate the immune system. Commonly prescribed agents include rituximab (Rituxan) and cyclophosphamide (Cytoxan). These medications are powerful and require careful monitoring by a clinical team to manage potential side effects.

What is the role of surgery and rehabilitation?

For patients where a tumor (most commonly an ovarian teratoma) is identified, surgical resection is a critical component of treating Anti-NMDA receptor encephalitis. Beyond medicine, recovery often requires a multidisciplinary approach. Physical therapy, occupational therapy, and speech-language pathology are essential for regaining motor function and cognitive clarity during the long recovery phase, which can take months or even years.

How does the care team support recovery?

Managing Anti-NMDA receptor encephalitis requires a coordinated team of specialists. Your care team should include a neurologist (specializing in neuroimmunology), a psychiatrist (to manage neuropsychiatric symptoms), and a physical medicine and rehabilitation (physiatrist) specialist. With 76 members currently sharing their experiences on DiseaseMaps.org, we have seen that individualized, early intervention is the most significant factor in long-term outcomes for those living with Anti-NMDA receptor encephalitis.

Next steps

• Consult with a neuroimmunologist to ensure your treatment plan reflects the most current clinical guidelines.


• Join our community at DiseaseMaps.org to connect with others who have navigated the recovery process for Anti-NMDA receptor encephalitis.


• Maintain a detailed log of medication responses and behavioral changes to assist your clinical team in making data-driven adjustments.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Anti-NMDA receptor encephalitis


• The Encephalitis Society


• Autoimmune Encephalitis Alliance